{
    "2020-12-16": [
        [
            {
                "time": "2021-01-01",
                "original_text": "2021年医药行业投资策略：继续乐观",
                "features": {
                    "keywords": [
                        "医药",
                        "行业",
                        "投资策略",
                        "乐观"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-05-10",
                "original_text": "风口上的猪，朗姿股份欲借医美赛道逆风翻盘？",
                "features": {
                    "keywords": [
                        "朗姿股份",
                        "医美",
                        "逆风翻盘"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医美"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-06-15",
                "original_text": "闪崩！10分钟内4只A股一起跌停，怎么回事？ 连续下跌",
                "features": {
                    "keywords": [
                        "闪崩",
                        "A股",
                        "跌停",
                        "连续下跌"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "A股"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-11-30",
                "original_text": "2021年医药生物行业策略报告：聚焦黄金赛道，寻找疫后高光",
                "features": {
                    "keywords": [
                        "医药生物",
                        "黄金赛道",
                        "疫后高光"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-07-20",
                "original_text": "国盛策略:A股大部分消费行业PE偏高或合理、业绩增速更优或中等",
                "features": {
                    "keywords": [
                        "国盛策略",
                        "A股",
                        "消费行业",
                        "PE",
                        "业绩增速"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "消费行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-09-12",
                "original_text": "创新药龙头暴涨7.67%，带动A股医药板块上攻",
                "features": {
                    "keywords": [
                        "创新药",
                        "龙头",
                        "暴涨",
                        "医药板块",
                        "上攻"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-10-25",
                "original_text": "投资机会何在？医药股连续反弹，政策面阶段不确定性有望消除",
                "features": {
                    "keywords": [
                        "投资机会",
                        "医药股",
                        "连续反弹",
                        "政策面",
                        "不确定性"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}